By Scottish influencer and finance manager Danielle Quinn has died at the age of 41 following a rare form of ovarian cancer. Her death was announced in October 2026 by her partner Ryan, who paid tribute to her openness and resilience.
Danielle Quinn’s ovarian cancer story has resonated because of how it began. She experienced abdominal pain and persistent bloating ovarian cancer can cause, which were initially attributed to irritable bowel syndrome or gastroenteritis. Further tests, including a CT scan, later revealed serious abnormalities and led to a diagnosis of stage 3 low-grade serous ovarian carcinoma in December 2022.
Her experience reflects a wider clinical challenge: early signs of ovarian cancer can be vague, come and go, and overlap with common digestive conditions. Most people with bloating or changes in bowel habit do not have ovarian cancer, but symptoms that are new, frequent, persistent or worsening deserve medical attention. This article explains ovarian cancer education in depth, using Danielle’s story respectfully to support awareness.
Who Was Danielle Quinn, and What Happened?
Scottish influencer Danielle Quinn, 41, from Glasgow, worked as a finance manager and ran a social media content creation business. According to reporting by STV News, Glasgow Times and her own account published by Beatson Cancer Charity, key events included:
- Danielle Quinn ovarian cancer symptoms began with abdominal pain and persistent bloating.
- Symptoms were initially attributed to IBS or gastroenteritis, a common experience reported by many people later diagnosed with ovarian cancer.
- A CT scan revealed abnormalities, leading to a diagnosis of stage 3 low-grade serous ovarian carcinoma just days before Christmas 2022.
- She underwent extensive debulking surgery lasting approximately seven hours, during which multiple organs and organ parts were removed, as she described herself.
- She initially chose hormone therapy rather than chemotherapy, an approach sometimes considered for low-grade serous disease.
- She openly documented her treatment, surgical menopause, emotional impact and day-to-day life.
- Her cancer returned in October 2024.
- She later entered hospice care in Ayrshire.
- Her death was announced in October 2026, with her partner Ryan Gardiner paying tribute and fundraising for Beatson Cancer Charity and Ayrshire Hospice.
Her case illustrates diagnostic challenges but does not establish that an earlier diagnosis would necessarily have changed her outcome. Low-grade serous carcinoma behaves differently from more common ovarian cancers, and individual outcomes depend on many factors beyond timing of diagnosis.
What Is Ovarian Cancer?
Ovarian cancer occurs when abnormal cells in or near the ovaries grow uncontrollably and form tumours.
The ovaries are two small organs in the female reproductive system that produce eggs and hormones such as oestrogen and progesterone. They sit on either side of the uterus, close to the fallopian tubes.
Cancer can start in several places:
- Epithelial ovarian cancer is the most common type, developing from cells on the surface of the ovary or fallopian tube lining. Many high-grade serous cancers now are understood to begin in the fimbriated end of the fallopian tube and then spread to the ovary.
- Germ cell tumours develop from egg-producing cells and are less common, often affecting younger people.
- Stromal tumours develop from hormone-producing connective tissue.
Ovarian cancer may spread within the abdomen by shedding cells that implant on the peritoneum, omentum and bowel surfaces. Because the abdominal cavity has space, tumours can grow and produce fluid (ascites) before causing severe pain, which is why symptoms can be subtle early on.
What is low-grade serous ovarian cancer?
Low-grade serous ovarian cancer is a rare subtype of epithelial ovarian cancer, accounting for a small percentage of all serous carcinomas. Unlike high-grade serous cancer, which grows quickly and often responds initially to chemotherapy, low-grade serous carcinoma tends to grow more slowly, is often diagnosed in younger women, and may be less sensitive to traditional chemotherapy. This is why hormone therapy, targeted treatments and surgery play a more central role in its management. Danielle Quinn was diagnosed with this subtype, stage 3 low-grade serous ovarian carcinoma.
Early Signs and Symptoms of Ovarian Cancer
According to the NHS and Cleveland Clinic, ovarian cancer symptoms may include:
- Persistent abdominal bloating or a swollen tummy that does not come and go
- Pelvic or abdominal pain or tenderness
- Feeling full quickly when eating (early satiety)
- Loss of appetite
- Frequent or urgent urination
- Changes in bowel habits, such as constipation or diarrhoea
- Unexplained abdominal swelling or increase in abdominal size
- Persistent indigestion or nausea
- Unexplained fatigue that does not improve with rest
- Unexplained weight loss or weight gain
- Vaginal bleeding that is not part of a normal period, particularly after menopause
These symptoms are common and most often have non-cancerous causes. What makes ovarian cancer more concerning is pattern: symptoms that are new for you, happen more than 12 times a month, persist for several weeks, and are getting worse rather than settling. The charity Ovacome emphasises keeping a symptom diary noting frequency, severity and change over time.
Ovarian Cancer vs IBS: Why Symptoms Can Be Confused
Ovarian cancer vs IBS is a frequent source of confusion for patients and clinicians because both can cause bloating, abdominal pain, changes in bowel habit and feeling full quickly.
Key differences that clinicians consider:
- Age and onset: IBS often begins in younger adulthood and fluctuates over many years. New, persistent bowel symptoms starting after age 50, or a marked change in pattern, warrant further assessment.
- Frequency and persistence: Ovarian cancer symptoms tend to be progressive and present almost daily, rather than intermittent and linked clearly to diet or stress.
- Associated features: Urinary urgency, persistent pelvic pain, abdominal swelling with fluid, and unexplained fatigue or weight loss are more suggestive of an ovarian cause and less typical of IBS alone.
- Response to usual measures: IBS symptoms may improve with diet, stress management or bowel-directed treatments; ovarian cancer symptoms generally do not.
IBS does not cause ovarian cancer. However, because symptoms overlap, NHS guidance recommends that people with new or changing abdominal symptoms have an examination and appropriate tests rather than assuming IBS without assessment.
What Causes Ovarian Cancer?
There is no single cause for all cases of ovarian cancer. Cancer develops when genetic changes allow cells to grow unchecked, and this can happen due to a combination of inherited and acquired factors.
Established ovarian cancer risk factors include:
- Increasing age: Risk rises after menopause, with most cases diagnosed after age 50, but it can occur in younger women.
- Family history: Having a close relative with ovarian or breast cancer increases risk.
- Inherited gene mutations: Pathogenic variants in BRCA1 and BRCA2 significantly increase risk for ovarian and breast cancer. These genes normally help repair DNA.
- Lynch syndrome: An inherited condition that increases risk of several cancers, including ovarian and womb cancers.
- Endometriosis: Associated with a higher risk of certain subtypes, particularly clear cell and endometrioid ovarian cancers, though absolute risk remains low.
- Reproductive and hormonal factors: Never having been pregnant, later menopause, and certain hormone replacement therapies are associated with modest risk changes. Combined oral contraceptive use for several years is associated with a lower risk in the general population.
- Other factors: Obesity, smoking (for mucinous subtypes) and tall height have been linked to small increases in risk in population studies.
Importantly, many people with no known risk factors develop ovarian cancer, and many with risk factors never do. Having a risk factor does not mean cancer is inevitable.
How Is Ovarian Cancer Diagnosed?
An ovarian cancer diagnosis usually involves several steps:
- Medical history and symptom assessment: How long symptoms have lasted, how often they occur and whether they are worsening.
- Pelvic examination: To feel for masses or swelling.
- Ultrasound: Often a transvaginal ultrasound to look at ovaries in detail.
- CA-125 blood test: CA-125 is a protein that can be higher in ovarian cancer but also in many benign conditions such as endometriosis, fibroids, infection or even menstruation.
- CT or MRI scans: If ovarian cancer is suspected, to assess spread within the abdomen and pelvis.
- Referral to a gynaecological cancer specialist (gynaecological oncologist): Recommended when tests suggest cancer.
- Tissue diagnosis: Removal or biopsy of tissue examined by a pathologist is needed to confirm diagnosis, subtype and grade.
There is currently no reliable routine screening programme for ovarian cancer in average-risk, asymptomatic women. Large UK trials showed that CA-125 and ultrasound screening did not reduce deaths from ovarian cancer in the general population, according to Cancer Research UK.
CA-125 has limitations: a normal result does not exclude ovarian cancer, and an elevated result does not automatically mean cancer. It is one piece of information interpreted alongside symptoms and imaging.
Stages of Ovarian Cancer
Ovarian cancer stages describe how far cancer has spread. Stage alone does not determine an individual’s outcome; subtype, grade, genetic features, general health and response to treatment also matter.
| Stage | General Extent |
|---|---|
| Stage 1 | Cancer is confined to one or both ovaries. May include capsule rupture or cancer cells in peritoneal washings, but no spread beyond ovaries. |
| Stage 2 | Cancer involves one or both ovaries and has spread within the pelvis, for example to uterus, fallopian tubes, bladder or rectum. |
| Stage 3 | Cancer has spread beyond the pelvis into the abdominal cavity, such as to the lining of the abdomen (peritoneum), omentum or lymph nodes in abdomen. Danielle Quinn was diagnosed with stage 3 ovarian cancer. |
| Stage 4 | Cancer has spread to distant sites outside the abdomen, such as liver parenchyma, lungs or distant lymph nodes, with fluid around lungs containing cancer cells. |
Each stage is further divided into A, B and C subcategories based on precise size and location of deposits, defined by the International Federation of Gynaecology and Obstetrics (FIGO) system.
Ovarian Cancer Treatment Options
Ovarian cancer treatment depends on subtype, stage, genetic test results, prior treatments and a person’s overall health and preferences. Treatment is usually coordinated by a multidisciplinary team.
- Surgery: Often the first step to remove as much cancer as possible (debulking or cytoreduction). This may involve removal of ovaries, fallopian tubes, uterus, omentum and peritoneal deposits. In Danielle’s case, extensive surgery lasting about seven hours with removal of multiple organs was reported.
- Chemotherapy: Drugs that kill rapidly dividing cells, commonly carboplatin and paclitaxel, used before or after surgery for many high-grade epithelial cancers.
- Targeted therapy: Including PARP inhibitors (such as olaparib, niraparib) for cancers with BRCA mutations or homologous recombination deficiency, and anti-angiogenic therapy such as bevacizumab that targets blood supply to tumours.
- Hormonal therapy: For selected subtypes, particularly low-grade serous carcinoma, which often expresses hormone receptors. Treatments such as letrozole or tamoxifen may be used to slow growth. Danielle initially chose hormone therapy.
- Maintenance treatment: Ongoing therapy after initial chemotherapy to delay recurrence, tailored to genetic features.
- Treatment for recurrent ovarian cancer: May include further surgery, different chemotherapy combinations, targeted agents or clinical trials.
- Symptom management and palliative care: Focuses on controlling symptoms such as pain, fluid buildup and bowel effects, supporting quality of life at any stage, not only end of life.
Low-grade serous ovarian carcinoma may require a different approach from high-grade disease because it tends to grow slowly and is often less responsive to standard chemotherapy. Decisions are individual and made with specialists, considering molecular testing and prior response.
Can Ovarian Cancer Be Cured?
Terms used in cancer care can be confusing:
- Cure means no evidence of cancer after treatment and no expectation of return.
- Remission means signs and symptoms of cancer have reduced or disappeared; partial or complete.
- Recurrence means cancer has returned after a period of remission.
- Disease control means treatment is keeping cancer stable or growing slowly, often with good quality of life.
Outcomes vary widely. Factors include stage at diagnosis, subtype and grade, completeness of surgery, genetic profile, age and general health.
According to Cancer Research UK for England and Wales (data similar for Scotland), almost 80% of women survive for one year or more after ovarian cancer diagnosis, and more than 50% survive five years or more across all stages combined. Survival is much higher when diagnosed at stage 1 compared with stage 4. For example, Cancer Research UK notes around 15% five-year survival for stage 4 disease, illustrating why stage matters but is not the whole picture.
In the US, the National Cancer Institute’s SEER data show five-year relative survival around 50% for all ovarian cancers combined, with wide variation by stage and subtype. These population statistics describe groups, not individuals, and cannot predict lifespan for any one person.
When Should Someone See a Doctor?
See a GP if you have:
- Persistent bloating that does not go away
- Pelvic or abdominal pain that is new and frequent
- Feeling full quickly or loss of appetite lasting three weeks or more
- Needing to urinate more often or urgently than usual, without a urinary infection
- Changes in bowel habit that are persistent and unusual for you
- Unexplained fatigue, weight loss or abdominal swelling
It helps to note when symptoms started, how often they occur, whether they are getting worse, and any relation to periods, diet or stress. Bring a brief diary if possible.
Seek urgent medical assessment for severe, sudden abdominal pain, rapid abdominal swelling, vomiting with inability to keep fluids down, or heavy vaginal bleeding. If you have a known BRCA mutation or strong family history of ovarian or breast cancer, discuss risk assessment and referral to genetics services.
Remember, most people with these symptoms will not have ovarian cancer, but persistent changes should be checked.
What Danielle Quinn’s Story Teaches Us About Ovarian Cancer Awareness
Returning to Danielle Quinn’s cancer battle, her story highlights several lessons without implying that every similar experience indicates cancer or that late diagnosis equals negligence:
- Recognising changes: Danielle noticed persistent bloating and pain that differed from her usual health. Paying attention to new patterns is valuable.
- Overlapping symptoms: Gastrointestinal and gynaecological symptoms can mimic each other, making clinical assessment and follow-up important when symptoms persist.
- Value of investigation: When initial explanations do not fit the course of symptoms, further tests such as ultrasound and CT imaging, and referral to specialists, can clarify the cause.
- Patient advocacy: Documenting symptoms, asking questions and seeking second opinions where appropriate are part of informed care.
- Need for awareness and support: Charities such as Beatson Cancer Charity, Ovacome and Cancer Research UK provide information, peer support and funding for research into rarer subtypes like low-grade serous carcinoma.
Danielle openly shared her surgical menopause, treatment decisions and emotional experiences, helping others understand what living with stage 3 ovarian cancer can involve. Her partner and family have asked for continued support for cancer charities in her memory. Her contribution to ovarian cancer awareness is remembered with gratitude and respect.
Frequently Asked Questions
What are the first warning signs of ovarian cancer?
The most commonly reported early signs are persistent bloating, pelvic or abdominal pain, feeling full quickly or loss of appetite, and needing to urinate more frequently or urgently. These symptoms are common and often benign, but if they are new, occur more than 12 times a month, last over three weeks and are getting worse, they should be assessed by a GP.
Can ovarian cancer symptoms be mistaken for IBS?
Yes. Bloating, abdominal pain, changes in bowel habit and early fullness occur in both conditions. IBS typically starts younger, fluctuates over years and may relate to diet or stress. Ovarian cancer symptoms tend to be persistent, progressive and new. If IBS-like symptoms start after age 50 or change markedly, further investigation is recommended.
What type of ovarian cancer did Danielle Quinn have?
Danielle Quinn had stage 3 low-grade serous ovarian carcinoma, a rare subtype of epithelial ovarian cancer that grows more slowly than high-grade serous cancer and may be managed differently, often with surgery and hormonal therapy. She was diagnosed in December 2022.
How old was Danielle Quinn when she died?
Scottish influencer Danielle Quinn died at age 41. Her death was announced in October 2026 after she had entered hospice care following a recurrence in October 2024.
Can ovarian cancer occur in younger women?
Yes. While risk increases with age, ovarian cancer can occur at any adult age. Germ cell tumours often affect people in their teens and twenties, and low-grade serous carcinoma is often diagnosed in younger women than high-grade serous cancer. Any persistent concerning symptoms should be evaluated regardless of age.
Is stage 3 ovarian cancer treatable?
Stage 3 ovarian cancer means cancer has spread beyond the pelvis into the abdominal cavity. It is generally not considered curable with surgery alone but is treatable. Treatment usually aims to remove as much cancer as possible and control remaining disease with chemotherapy, targeted therapy, hormonal therapy or clinical trials. Outcomes vary by subtype, response and individual factors.
Can a blood test detect ovarian cancer?
No single blood test reliably detects ovarian cancer on its own. CA-125 is a protein that may be elevated in ovarian cancer but also in many benign conditions, and it can be normal in some cancers. It is used alongside ultrasound, symptom assessment and specialist referral, not as a standalone screening test for the general population.
What is the survival rate for ovarian cancer?
Survival varies greatly by stage, subtype and country. In England and Wales, Cancer Research UK reports that almost 80% of women survive one year and more than 50% survive five years across all stages combined. Five-year survival is much higher for stage 1 disease and lower for stage 4. Population statistics cannot predict an individual’s outcome. Talk to your specialist team for information relevant to your situation.
Medical information disclaimer: This article is for general information and does not provide medical advice. It is not a substitute for professional medical assessment, diagnosis or treatment. If you have symptoms or concerns about ovarian cancer, please speak to a qualified healthcare professional promptly. If you need support, you can contact your GP, NHS 111, or charities such as Ovacome and Beatson Cancer Charity.
Dr. Samuel Kemp is a Consultant Physician at the Royal Brompton Hospital with specialist expertise in respiratory medicine, including lung cancer, COPD, and advanced interventional bronchoscopy.